Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,398 INR | -4.44% | +7.29% | +3.12% |
Sales 2024 | 16.94B 203M | Sales 2025 * | 19.67B 235M | Capitalization | 111B 1.33B |
---|---|---|---|---|---|
Net income 2024 | 4.57B 54.72M | Net income 2025 * | 5.23B 62.57M | EV / Sales 2024 | 5.91 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.65 x |
P/E ratio 2024 |
22
x | P/E ratio 2025 * |
21.2
x | Employees | 1,642 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.23% | Free-Float | 25.34% |
Latest transcript on Caplin Point Laboratories Limited
1 day | -4.44% | ||
1 week | +7.29% | ||
Current month | +8.44% | ||
1 month | +7.10% | ||
3 months | +9.68% | ||
6 months | +14.66% | ||
Current year | +3.12% |
Managers | Title | Age | Since |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28/15/28 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 19/16/19 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 01/10/01 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28/15/28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 114 M€ | +5.60% | - |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 1,398 | -4.44% | 23 409 |
12/24/12 | 1,463 | +0.40% | 4,283 |
11/24/11 | 1,458 | -1.22% | 7,604 |
10/24/10 | 1,476 | +8.03% | 94,040 |
07/24/07 | 1,366 | +4.79% | 5,912 |
Delayed Quote Bombay S.E., June 13, 2024 at 03:30 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.12% | 1.33B | |
+19.96% | 43.32B | |
+20.38% | 22.81B | |
+17.41% | 15.32B | |
+23.93% | 14.91B | |
+58.23% | 13.23B | |
-0.05% | 6.79B | |
-15.52% | 6.51B | |
-8.87% | 5.73B | |
+12.39% | 5.53B |
- Stock Market
- Equities
- CAPLIPOINT Stock